0001047469-10-008009 Sample Contracts

Contract
Anacor Pharmaceuticals Inc • September 10th, 2010 • Pharmaceutical preparations • California

THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "1933 ACT"), OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD OR TRANSFERRED UNLESS SUCH SALE OR TRANSFER IS IN ACCORDANCE WITH THE REGISTRATION REQUIREMENTS OF SUCH ACT AND APPLICABLE LAWS OR SOME OTHER EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND APPLICABLE LAWS IS AVAILABLE WITH RESPECT THERETO.

Sample 1Sample 2Sample 3See All (8)
AutoNDA by SimpleDocs
ANACOR PHARMACEUTICALS, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENT
Change of Control and Severance Agreement • September 10th, 2010 • Anacor Pharmaceuticals Inc • Pharmaceutical preparations • California

This Change of Control and Severance Agreement (the "Agreement") is dated as of August 21, 2007, by and between David P. Perry ("Employee") and Anacor Pharmaceuticals, Inc., a Delaware corporation (the "Company" or "Anacor"). This Agreement is intended to provide Employee with certain benefits described herein upon the occurrence of specific events.

Sample 1Sample 2
RESEARCH AND DEVELOPMENT COLLABORATION, OPTION AND LICENSE AGREEMENT BETWEEN SMITHKLINE BEECHAM CORPORATION D/B/A GLAXOSMITHKLINE and ANACOR PHARMACEUTICALS, INC.
Research and Development Collaboration, Option and License Agreement • September 10th, 2010 • Anacor Pharmaceuticals Inc • Pharmaceutical preparations • New York

This RESEARCH AND DEVELOPMENT COLLABORATION, OPTION AND LICENSE AGREEMENT (the "Agreement") is entered into and made effective as of the 5th day of October, 2007 (the "Effective Date") by and between Anacor Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at 1060 East Meadow Circle, Palo Alto, CA 94303 ("Anacor"), and SmithKline Beecham Corporation d/b/a GlaxoSmithKline, a Pennsylvania corporation having offices at One Franklin Plaza, Philadelphia, PA 19101 ("GSK"). Anacor and GSK are each referred to herein by name or as a "Party" or, collectively, as "Parties."

Sample 1Sample 2
ANACOR PHARMACEUTICALS, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENT
Control and Severance Agreement • September 10th, 2010 • Anacor Pharmaceuticals Inc • Pharmaceutical preparations • California

This Change of Control and Severance Agreement (the "Agreement") is dated as of [ ], by and between ("Employee") and Anacor Pharmaceuticals, Inc., a Delaware corporation (the "Company" or "Anacor"). This Agreement is intended to provide Employee with certain benefits described herein upon the occurrence of specific events.

Sample 1Sample 2
Contract
Anacor Pharmaceuticals Inc • September 10th, 2010 • Pharmaceutical preparations • California

THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "1933 ACT"), OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD OR TRANSFERRED UNLESS SUCH SALE OR TRANSFER IS IN ACCORDANCE WITH THE REGISTRATION REQUIREMENTS OF SUCH ACT AND APPLICABLE LAWS OR SOME OTHER EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND APPLICABLE LAWS IS AVAILABLE WITH RESPECT THERETO.

Sample 1Sample 2
Confidential Separation Agreement and General Release of Claims Dear Chris:
Anacor Pharmaceuticals Inc • September 10th, 2010 • Pharmaceutical preparations • California

This letter confirms the agreement between you and Anacor Pharmaceuticals, Inc. (the "Company") concerning the terms of your resignation and separation from the Company and offers you the consulting arrangement we discussed in exchange for a release of claims.

Sample 1
ANACOR PHARMACEUTICALS, INC. CONSULTING AGREEMENT
Consulting Agreement • September 10th, 2010 • Anacor Pharmaceuticals Inc • Pharmaceutical preparations • California

This Consulting Agreement (the "Agreement") is entered into by and between Anacor Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Stephen J. Benkovic, Ph.D. ("Consultant").

Sample 1
CONSULTING AGREEMENT
Consulting Agreement • September 10th, 2010 • Anacor Pharmaceuticals Inc • Pharmaceutical preparations • California

This CONSULTING AGREEMENT is effective as of April 13, 2010 ("Agreement") between Anacor Pharmaceuticals, Inc. ("Company") and Christine Gray-Smith ("Consultant"). Company and Consultant are collectively the Parties and each a Party.

Sample 1
ANACOR PHARMACEUTICALS, INC. A DELAWARE CORPORATION AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT December 24, 2008
Investors' Rights Agreement • September 10th, 2010 • Anacor Pharmaceuticals Inc • Pharmaceutical preparations • California

This Amended and Restated Investors' Rights Agreement (this "Agreement") is made as of December 24, 2008, by and among Anacor Pharmaceuticals, Inc., a Delaware corporation (the "Company"), the investors listed on Exhibit A hereto (each, an "Investor"), The Pennsylvania State University and Stanford University.

Sample 1
ANACOR PHARMACEUTICALS, INC. BOARD OF DIRECTORS AND ADVISORY BOARD AGREEMENT
Advisory Board Agreement • September 10th, 2010 • Anacor Pharmaceuticals Inc • Pharmaceutical preparations • California

This Advisory Board Agreement (the "Agreement") is entered into as of November 9, 2005 between Anacor Pharmaceuticals, Inc., a Delaware corporation (the "Company") and Lucy Shapiro, Ph.D. ("Advisor").

Sample 1
LOAN AND SECURITY AGREEMENT
Loan and Security Agreement • September 10th, 2010 • Anacor Pharmaceuticals Inc • Pharmaceutical preparations • California

THIS LOAN AND SECURITY AGREEMENT NO. 5251 (this "Agreement") is entered into as of June 30, 2006, by and between LIGHTHOUSE CAPITAL PARTNERS V, L.P. ("Lender") and ANACOR PHARMACEUTICALS, INC., a Delaware corporation ("Borrower") and sets forth the terms and conditions upon which Lender will lend and Borrower will repay money. In consideration of the mutual covenants herein contained, the parties agree as follows:

Sample 1
Anacor Pharmaceuticals, Inc. Change of Control Agreement for Stephen Benkovic, Ph.D.
Anacor Pharmaceuticals Inc • September 10th, 2010 • Pharmaceutical preparations

In the event of a Change of Control of Anacor Pharmaceuticals, Inc. (the "Company"), all restricted stock and stock options granted to you by by the Company and held by you shall immediately vest as of the date immediately prior to the effective date of the Change of Control transaction. For purposes of this Agreement, a "Change of Control" shall mean a sale of all or substantially all of the Company's assets, or any merger or consolidation of the Company with or into another corporation other than a merger or consolidation in which the holders of more than 50% of the shares of capital stock of the Company outstanding immediately prior to such transaction continue to hold (either by voting securities remaining outstanding or by their being converted into voting securities of the surviving entity) more than 50% of the total voting power represented by the voting securities of the Company, or such surviving entity, outstanding immediately after such transaction. For purposes of clarifica

Sample 1
LEASE OF PALO ALTO, CALIFORNIA BY AND BETWEEN CALIFORNIA PACIFIC COMMERCIAL CORPORATION, A CALIFORNIA CORPORATION, LANDLORD AND ANACOR PHARMACEUTICALS, INC. A DELAWARE CORPORATION, TENANT
Work Letter Agreement • September 10th, 2010 • Anacor Pharmaceuticals Inc • Pharmaceutical preparations • California

This Lease, dated October 5, 2007, is made and entered into by and between CALIFORNIA PACIFIC COMMERCIAL CORPORATION, a California corporation ("Landlord"), and ANACOR PHARMACEUTICALS, INC., a Delaware corporation ("Tenant").

Sample 1
ANACOR PHARMACEUTICALS, INC. CONSULTING AGREEMENT
Consulting Agreement • September 10th, 2010 • Anacor Pharmaceuticals Inc • Pharmaceutical preparations • California

This Consulting Agreement (the "Agreement") is entered into by and between Anacor Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Geoffrey M. Parker ("Consultant").

Sample 1
Anacor Pharmaceuticals, Inc. Change of Control Agreement for Lucy Shapiro, Ph.D.
Anacor Pharmaceuticals Inc • September 10th, 2010 • Pharmaceutical preparations

In the event of a Change of Control of Anacor Pharmaceuticals, Inc. (the "Company"), all restricted stock and stock options granted to you by the Company and held by you shall immediately vest as of the date immediately prior to the effective date of the Change of Control transaction. For purposes of this Agreement, a "Change of Control" shall mean a sale of all or substantially all of the Company's assets or of equity securities representing more than 50% of the total voting power of the Company, or any merger or consolidation of the Company with or into another corporation other than a merger or consolidation in which the holders of more than 50% of the shares of capital stock of the Company outstanding immediately prior to such transaction continue to hold (either by voting securities remaining outstanding or by their being converted into voting securities of the surviving entity) more than 50% of the total voting power represented by the voting securities of the Company, or such su

Sample 1
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!